Flow Partners advises Code Pharma

Providing confidential valuation guidance to Code Pharma, a global biotech company and the developer of the effective antiviral COVID-19 therapy.

Utrecht, Netherlands — 07 July 2021

Flow Partners acted as a financial advisor to a Dutch biotech company Code Pharma that aims to develop cost effective treatments for infectious and oncological diseases by using novel peptides.

Overview

Management of Code Pharma required an actionable valuation service in order to accurately position the business in the upcoming capital raising discussions.

We have provided an independent valuation opinion that included development pipeline analysis, risk-adjusted NPV (rNPV), comparable environment analysis, operational benchmarking, green/red flag analysis and more.

This transaction highlights our strong track record in digital health and biotech space, having also advised and valued companies like AVE & YOU (personalized skincare) or BiomX (biotechnology).

About Code Pharma

Founded in 2014, Code Pharma aims to develop cost effective treatments for infectious and oncological diseases by using novel peptides. The company brought together outstanding professionals with multidisciplinary expertise in peptides, cell cultures, clinical development and chemistry manufacturing. Headquatered in Netherlands, Code Pharma acquires peptides from Hebrew University of Jerusalem and keeps its R&D center in Israel.

About Flow Partners

Flow Partners is a modern advisory firm providing independent corporate finance advice to companies and investors that shape the global digital ecosystem. Flow was founded in 2020 and operates globally with presence in London, Berlin, Warsaw and Miami.

For more information, please visit www.flowpartners.io

Enquiries

For all enquiries please contact the team at [email protected]

Relevant Client Successes

acquisition by

MAILINGWORK is a German email marketing software platform.

acquisition by

TestSolutions is a German software testing provider.

strategic advisory

Element is one of the world’s leading providers of testing, inspection, and certification services.

acquisition by

Rebellion is a Spanish neobanking plaform for Gen Z and Millenials.

acquisition by

HAPPYCAR is an online price comparison and booking platform for rental cars.

investment by

GoTrendier is an online marketplace to buy second-hand clothing in Mexico and Colombia.

potential acquisition by

Testing, Inspection & Certification Player

Resillion (formerly Eurofins Digital Testing) is a digital testing, cybersecurity, content and digital forensics provider.

acquisition by

Pure is an online platform and mobile app for casual dating, catering to curious and adventure-seeking individuals.

investment by

Undisclosed Buyer

Ziik is all-in-one internal communication and information sharing platform for better employee engagement.

investment by

Krita is the leading factoring platform operating in the Icelandic market.

investment by

Orka owns a portfolio of online consumer lending platforms operating in Iceland.

investment by

Sentryc is an AI-driven software solution to protect intellectual property and brand reputation online.

investment by

Legendary Play is a mobile gaming studio focused on esports community.

investment by

MILES is the largest independent car sharing provider operating in Germany.

investment by

Picus Security is a Turkey-based cybersecurity platform focused on Breach-and-Attack Simulation vertical.

investment by

sevDesk is an accounting software platform for SMEs and freelancers in Germany and Austria.

investment by

Metaloop (formerly Schrott24) is an online marketplace for scrap metal trading.

European Satellite & Terrestrial Network Provider

potential investment by

Key Family Partners (KFP) is a Geneva-based multi-family office.

Fiber To The Home (FTTH) Provider

potential investment by

Key Family Partners (KFP) is a Geneva-based multi-family office.

valuation advisory

Code Pharma is a Europe-wide online marketplace for efficient “last mile” vehicle transfer.

valuation advisory

Hector is a display advertising platform providing software house with expertise in AI/ML, IoT.

valuation advisory

Panorays is a a software platform for third-party security management.

valuation advisory

Percepto is an autonomous drone monitoring solutions for critical infrastructure and industrial sites.

valuation advisory

Selina is a travel and lifestyle hospitality platform targeted for digital nomads.

valuation advisory

Code Pharma is a financial platform that focuses on fundraising for private equity and investment industry.

valuation advisory

Seagull Maritime is a maritime cybersecurity and protective services company.

valuation advisory

Moburst is a global marketing services company that helps brands grow their mobile business.

valuation advisory

Lemonade is a full-stack insurance company powered by AI and behavioral economics.

valuation advisory

Testim is an AI-based software testing automation platform for application testing.

valuation advisory

Brew is a generative AI platform designed for marketing teams.

valuation advisory

BiomX is a clinical stage microbiome therapeutics company.

valuation advisory

Code Pharma develops cost-effective treatments for infectious and oncological diseases by using novel peptides.

investment by

Undisclosed Investors

AVE & YOU is a technology platform and DTC brand for personalized skincare.

European Digital Asset Management (DAM) Software Provider

acquisition by

Byron Capital Partners manages multi-manager, private equity, real estate, fixed income and credit portfolio.

See all our track record

Our capabilities span across M&A, capital raising and strategic advisory.

All Experience

Providing confidential valuation guidance to Code Pharma, a global biotech company and the developer of the effective antiviral COVID-19 therapy.

Providing confidential valuation guidance to Code Pharma, an independent Swiss strategic advisory and execution platform.

Overview

About Code Pharma

About Flow Partners

Enquiries

Relevant Client Successes

See all our track record